SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001516551-23-000050
Filing Date
2023-08-22
Accepted
2023-08-22 17:19:15
Documents
3
Period of Report
2023-08-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1692739144.html 3  
1 FORM 3 wk-form3_1692739144.xml 3 1640
2 EX-24 projectaquila-powerofatt.htm EX-24 3591
3 GRAPHIC projectaquila-powerofatt001.jpg GRAPHIC 226696
  Complete submission text file 0001516551-23-000050.txt   319248
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Issuer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10578 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address
Grayson Paul A. (Reporting) CIK: 0001861554 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55136 | Film No.: 231194542